#grey-market-pharmacies

[ follow ]
#retatrutide #triple-agonist-glp-1gipgcg #weight-loss-drugs
Medicine
fromFuturism
1 day ago

People Are Injecting Themselves With an Experimental New Weight Loss Drug

Retatrutide, a triple-agonist targeting GLP-1, GIP, and GCG receptors, produced 24.2% average weight loss in 48 weeks and is spreading via grey-market pharmacies.
[ Load more ]